Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
AS LHV Group's April financial results reflected improved performance across all subsidiaries. LHV Group earned a consolidated net profit of EUR 8.7 million in April, with return on equity...
-
BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (“Elevra or Company”) (ASX:ELV; NASDAQ:ELVR) announced today the outcomes of an Updated...
-
RA'ANANA, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," "Inspira Technologies," or the "Company"), today issued a letter to its...
-
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted...
-
SIM0505/CDH6 ADC dose optimization initiated in gynecologic cancersSIM0505 Phase 1 dose escalation study data to be presented at ASCO 2026 LNCB74 Phase 1 dose escalation trial update planned in second...
-
New York, USA, May 07, 2026 (GLOBE NEWSWIRE) -- PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The PARP...
-
Issued on behalf of Greenland Mines Ltd The combined Pd-Au-Pt expression at Skaergaard — already one of the world’s largest undeveloped precious-metals systems — just stepped up by approximately 50%...
-
Issued on behalf of VisionWave Holdings, Inc. A platform expansion strategy that seeks to integrate xClibre AI video intelligence, Foresight 3D perception, and Israeli aerospace components with the...
-
Greenland Mines Ltd. (NASDAQ: GRML) and its 80%-owned Greenland subsidiary Major Precious Greenland A/S have been admitted to the European Raw Materials Alliance — the European Commission’s central...
-
PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...